Literature DB >> 12436249

Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren.

Kazue Endo1, Hisako Yanagi, Jungo Araki, Chiaki Hirano, Kimiko Yamakawa-Kobayashi, Shigeo Tomura.   

Abstract

The purpose of this study was to assess the influence of single nucleotide polymorphism 3 (SNP3) of the apolipoprotein A-V ( APOA5) gene on the serum triglyceride (TG) level in Japanese schoolchildren. To determine the frequency of the genotype, we analyzed 552 schoolchildren. The frequencies of the T/T, T/C and C/C genotypes of the APOA5 gene were 225 (40.8%), 263 (47.6%) and 64 (11.6%), respectively. The serum TG level was significantly different among the genotypic groups after adjustments for age, gender and obesity index (T/T 71.6+/-34.8 mg/dl, T/C 80.7+/-36.1 mg/dl, C/C 94.4+/-69.4 mg/dl, P<0.0001). The odds ratio (95% confidence interval) for hypertriglyceridemia of the C allele was 2.4 (1.0-6.2). Our data suggested that the T/C promoter region polymorphism of the APOA5 gene appears to be a genetic risk factor for hypertriglyceridemia in Japanese children.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12436249     DOI: 10.1007/s00439-002-0825-0

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  34 in total

Review 1.  Comparative genomic tools and databases: providing insights into the human genome.

Authors:  Len A Pennacchio; Edward M Rubin
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  Plasma apolipoprotein A5 and triglycerides in type 2 diabetes.

Authors:  G M Dallinga-Thie; A van Tol; H Hattori; L C van Vark-van der Zee; H Jansen; E J G Sijbrands
Journal:  Diabetologia       Date:  2006-04-28       Impact factor: 10.122

3.  Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.

Authors:  Christophe Marçais; Bruno Verges; Sybil Charrière; Valérie Pruneta; Micheline Merlin; Stéphane Billon; Laurence Perrot; Jocelyne Drai; Agnès Sassolas; Len A Pennacchio; Jamila Fruchart-Najib; Jean-Charles Fruchart; Vincent Durlach; Philippe Moulin
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

4.  Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11.

Authors:  Michael Olivier; Xujing Wang; Regina Cole; Brian Gau; Jessica Kim; Edward M Rubin; Len A Pennacchio
Journal:  Genomics       Date:  2004-05       Impact factor: 5.736

5.  Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia.

Authors:  Sophie Eichenbaum-Voline; Michael Olivier; Emma L Jones; Rossitza P Naoumova; Bethan Jones; Brian Gau; Hetal N Patel; Mary Seed; D John Betteridge; David J Galton; Edward M Rubin; James Scott; Carol C Shoulders; Len A Pennacchio
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-09       Impact factor: 8.311

6.  Apolipoprotein A5 polymorphisms in Turkish population: association with serum lipid profile and risk of ischemic stroke.

Authors:  Birsen Can Demirdöğen; Esra Şahin; Aysun Türkanoğlu Özçelik; Semai Bek; Şeref Demirkaya; Orhan Adali
Journal:  Mol Biol Rep       Date:  2012-10-13       Impact factor: 2.316

7.  The single nucleotide polymorphism -1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia.

Authors:  D Evans; A Buchwald; F U Beil
Journal:  J Mol Med (Berl)       Date:  2003-08-23       Impact factor: 4.599

8.  Cloning and characterization of a novel apolipoprotein gene, apolipoprotein AV, in tree shrews.

Authors:  Guoping Li; Huairong Luo; Guotao Sun; Guisheng Wu; Gang Wu; Yan Wang; Yong Man; Shu Wang; Jian Li; Baosheng Chen
Journal:  Mol Biol Rep       Date:  2013-05-17       Impact factor: 2.316

9.  Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome.

Authors:  Anita Maász; Péter Kisfali; Katalin Horvatovich; Márton Mohás; Lajos Markó; Veronika Csöngei; Bernadett Faragó; Luca Járomi; Lili Magyari; Enikô Sáfrány; Csilla Sipeky; István Wittmann; Béla Melegh
Journal:  Pathol Oncol Res       Date:  2007-10-07       Impact factor: 3.201

Review 10.  The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research.

Authors:  Mahdi Garelnabi; Kenton Lor; Jun Jin; Fei Chai; Nalini Santanam
Journal:  Clin Biochem       Date:  2012-09-19       Impact factor: 3.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.